Plasma Volume Expansion: The Current Controversy

  • C. Hartog
  • K. Reinhart
Chapter

Abstract

Although rapid and adequate administration of fluid is largely accepted as a mainstay of resuscitation in the critically ill patient, there is still an ongoing debate on the merits of colloids against crystalloids as first line plasma expanders. The underlying biologic rationale calls for rapid restoration of fluid losses to maintain circulating blood volume and organ perfusion.

Keywords

Severe Sepsis Acute Ischemic Stroke Intensive Care Unit Patient Mean Arterial Blood Pressure Hydroxyethyl Starch 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    van der Heijden M, Verheij J, van Nieuw Amerongen GP et al (2009) Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med 37:1275–1281CrossRefPubMedGoogle Scholar
  2. 2.
    Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139CrossRefPubMedGoogle Scholar
  3. 3.
    Perel P, Roberts I (2007) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev:CD000567Google Scholar
  4. 4.
    FDA, Center for Biologics Evaluation and Research. Product Approval Information — New Drug Applications. NDA REVIEW MEMO (MID-CYCLE). 6-MAR-2007. Last update 10-April-2008. Accessed on: 10-September-2008. Available from: http://www.fda.gov/CbER/nda/voluven.htm DOIGoogle Scholar
  5. 5.
    Barron ME, Wilkes MM, Navickis RJ (2004) A systematic review of the comparative safety of colloids. Arch Surg 139:552–563CrossRefPubMedGoogle Scholar
  6. 6.
    Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 317:235–240Google Scholar
  7. 7.
    Finfer S, Bellomo R, Boyce N et al (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256CrossRefPubMedGoogle Scholar
  8. 8.
    Myburgh J, Cooper DJ, Finfer S et al (2007) Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357:874–884CrossRefPubMedGoogle Scholar
  9. 9.
    Bunn F, Trivedi D, Ashraf S (2008) Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev:CD001319Google Scholar
  10. 10.
    Schortgen F, Lacherade JC, Bruneel F et al (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet 357:911–916CrossRefPubMedGoogle Scholar
  11. 11.
    Wills BA, Nguyen MD, Ha TL et al (2005) Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 353:877–889CrossRefPubMedGoogle Scholar
  12. 12.
    Verheij J, van Lingen A, Raijmakers PG et al (2006) Effect of fluid loading with saline or colloids on pulmonary permeability, oedema and lung injury score after cardiac and major vascular surgery. Br J Anaesth 96:21–30CrossRefPubMedGoogle Scholar
  13. 13.
    Aichner FT, Fazekas F, Brainin M et al (1998) Hypervolemic hemodilution in acute ischemic stroke: The Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke 29:743–749PubMedGoogle Scholar
  14. 14.
    Boldt J (2009) PRO: Hydroxyethyl starch can be safely used in the intensive care patient. Intensive Care Med (in press)Google Scholar
  15. 15.
    Hartog C, KR (2009) CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients. Intensive Care Med (in press)Google Scholar
  16. 16.
    Woessner R, Grauer MT, Dieterich HJ et al (2003) Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. Pathophysiol Haemost Thromb 33:121–126CrossRefPubMedGoogle Scholar
  17. 17.
    Rudolf J (2002) Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: A randomized, placebo-controlled phase II safety study. Cerebrovasc Dis 14:33–41CrossRefPubMedGoogle Scholar
  18. 18.
    Pillebout E, Nochy D, Hill G et al (2005) Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant 5:1120–1129CrossRefPubMedGoogle Scholar
  19. 19.
    Boldt J, Brosch C, Rohm K et al (2008) Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 100:457–464CrossRefPubMedGoogle Scholar
  20. 20.
    Sakr Y, Payen D, Reinhart K et al (2007) Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 98:216–224CrossRefPubMedGoogle Scholar
  21. 21.
    Boldt J, Brosch C, Ducke M et al (2007) Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: A comparison with human albumin. Crit Care Med 35:2740–2746CrossRefPubMedGoogle Scholar
  22. 22.
    Wiedermann CJ (2008) Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med 8:1CrossRefPubMedGoogle Scholar
  23. 23.
    Hagne C, Schwarz A, Gaspert A et al (2009) HAES in septic shock—Sword of Damocles? Schweiz Med Forum www.medicalforum.ch 9:304–306Google Scholar
  24. 24.
    Dickenmann M, Oettl T, Mihatsch MJ (2008) Osmotic nephrosis: Acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 51:491–503CrossRefPubMedGoogle Scholar
  25. 25.
    Schortgen F, Girou E, Deye N et al (2008) The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 34:2157–2168CrossRefPubMedGoogle Scholar
  26. 26.
    de Jonge E, Levi M (2001) Effects of different plasma substitutes on blood coagulation: A comparative review. Crit Care Med 29:1261–1267CrossRefPubMedGoogle Scholar
  27. 27.
    Wilkes MM, Navickis RJ, Sibbald WJ (2001) Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: A meta-analysis of postoperative bleeding. Ann Thorac Surg 72:527–533; discussion 534CrossRefPubMedGoogle Scholar
  28. 28.
    Haynes GR, Havidich JE, Payne KJ (2004) Why the Food and Drug Administration changed the warning label for hetastarch. Anesthesiology 101:560–561CrossRefPubMedGoogle Scholar
  29. 29.
    Jonville-Bera AP, Autret-Leca E, Gruel Y (2001) Acquired type I von Willebrand’s disease associated with highly substituted hydroxyethyl starch. N Engl J Med 345:622–623CrossRefPubMedGoogle Scholar
  30. 30.
    Neff TA, Doelberg M, Jungheinrich C et al (2003) Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 96:1453–1459CrossRefPubMedGoogle Scholar
  31. 31.
    Wiedermann CJ (2003) Complications of hydroxyethyl starch in acute ischemic stroke and other brain injuries. Pathophysiol Haemost Thromb 33:225–228; author reply 229–230CrossRefPubMedGoogle Scholar
  32. 32.
    Haynes GR (2004) Is hydroxyethyl starch safe in brain injury? Anesth Analg 99:620; author reply 620–622CrossRefPubMedGoogle Scholar
  33. 33.
    Sirtl C, Laubenthal H, Zumtobel V et al (1999) Tissue deposits of hydroxyethyl starch (HES): Dose-dependent and time-related. Br J Anaesth 82:510–515PubMedGoogle Scholar
  34. 34.
    Stander S, Evers S, Metze D et al (2005) Neurophysiological evidence for altered sensory function caused by storage of hydroxyethyl starch in cutaneous nerve fibres. Br J Dermatol 152:1085–1086CrossRefPubMedGoogle Scholar
  35. 35.
    Bork K (2005) Pruritus precipitated by hydroxyethyl starch: A review. Br J Dermatol 152:3–12CrossRefPubMedGoogle Scholar
  36. 36.
    Schmidt-Hieber M, Loddenkemper C, Schwartz S et al (2006) Hydrops lysosomalis generalisatus—An underestimated side effect of hydroxyethyl starch therapy? Eur J Haematol 77:83–85CrossRefPubMedGoogle Scholar
  37. 37.
    Auwerda JJ, Leebeek FW, Wilson JH et al (2006) Acquired lysosomal storage caused by frequent plasmapheresis procedures with hydroxyethyl starch. Transfusion 46:1705–1711CrossRefPubMedGoogle Scholar
  38. 38.
    Kasper SM, Meinert P, Kampe S et al (2003) Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 99:42–47CrossRefPubMedGoogle Scholar
  39. 39.
    Upadhyay M, Singhi S, Murlidharan J et al (2005) Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatr 42:223–231PubMedGoogle Scholar
  40. 40.
    Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI et al (2006) Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 102:998–1006CrossRefPubMedGoogle Scholar
  41. 41.
    Mahmood A, Gosling P, Vohra RK (2007) Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 94:427–433CrossRefPubMedGoogle Scholar
  42. 42.
    Wenham TN, Hormis AP, Andrzejowski JC (2008) Hypertonic saline after traumatic brain injury in UK neuro-critical care practice. Anaesthesia 63:558–559CrossRefPubMedGoogle Scholar
  43. 43.
    Bunn F, Roberts I, Tasker R et al (2004) Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochranne Database Syst Rev: CD002045Google Scholar
  44. 44.
    Waters JH, Gottlieb A, Schoenwald P et al (2001) Normal saline versus lactated Ringer’s solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: An outcome study. Anesth Analg 93:817–822CrossRefPubMedGoogle Scholar
  45. 45.
    Rackow EC, Falk JL, Fein IA et al (1983) Fluid resuscitation in circulatory shock: A comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 11:839–850CrossRefPubMedGoogle Scholar
  46. 46.
    Fink M, Abraham E, Vincent JL et al (2005) Textbook of critical care, 5th edn. Elsevier Saunders, PhiladelphiaGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • C. Hartog
    • 1
  • K. Reinhart
    • 1
  1. 1.Department of Anesthesiology and Intensive CareJena University Hospital, Friedrich-Schiller-UniversityJenaGermany

Personalised recommendations